These changes demonstrate that in Nf2-mutant cancers the canonical Wnt signaling pathway is highly activated and that the alterations in levels of Wnt ligands and inhibitors found at the transcriptional level translate into increased pathway activation (Fig. 3F). Here, NF2 is linked to cancer.